BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8333852)

  • 1. Suramin, an experimental chemotherapeutic drug, irreversibly blocks T cell CD45-protein tyrosine phosphatase in vitro.
    Ghosh J; Miller RA
    Biochem Biophys Res Commun; 1993 Jul; 194(1):36-44. PubMed ID: 8333852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tyrosine phosphorylation in isolated T cell membrane by inhibition of protein tyrosine phosphatases.
    Jin YJ; Friedman J; Burakoff SJ
    J Immunol; 1998 Aug; 161(4):1743-50. PubMed ID: 9712039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CD45 with Lck and components of the Ras signalling pathway in pervanadate-treated mouse T-cell lines.
    Lee JM; Fournel M; Veillette A; Branton PE
    Oncogene; 1996 Jan; 12(2):253-63. PubMed ID: 8570203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of integrin-mediated T cell adhesion by the transmembrane protein tyrosine phosphatase CD45.
    Shenoi H; Seavitt J; Zheleznyak A; Thomas ML; Brown EJ
    J Immunol; 1999 Jun; 162(12):7120-7. PubMed ID: 10358156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell development in mice expressing splice variants of the protein tyrosine phosphatase CD45.
    Kozieradzki I; Kündig T; Kishihara K; Ong CJ; Chiu D; Wallace VA; Kawai K; Timms E; Ionescu J; Ohashi P; Marth JD; Mak TW; Penninger JM
    J Immunol; 1997 Apr; 158(7):3130-9. PubMed ID: 9120266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD45 ligation induces programmed cell death in T and B lymphocytes.
    Klaus SJ; Sidorenko SP; Clark EA
    J Immunol; 1996 Apr; 156(8):2743-53. PubMed ID: 8609392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of CD45 protein tyrosine phosphatase activity to lipid microdomains on the T cell surface inhibits TCR signaling.
    He X; Woodford-Thomas TA; Johnson KG; Shah DD; Thomas ML
    Eur J Immunol; 2002 Sep; 32(9):2578-87. PubMed ID: 12207342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of lymphocyte CD45 protein tyrosine phosphatase activity during mitosis.
    Melkerson-Watson LJ; Waldmann ME; Gunter AD; Zaroukian MH; Esselman WJ
    J Immunol; 1994 Sep; 153(5):2004-13. PubMed ID: 8051405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative effects of suramin on lymphoid cells.
    Spigelman Z; Dowers A; Kennedy S; DiSorbo D; O'Brien M; Barr R; McCaffrey R
    Cancer Res; 1987 Sep; 47(17):4694-8. PubMed ID: 3621163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines.
    Sartor O; McLellan CA; Myers CE; Borner MM
    J Clin Invest; 1992 Dec; 90(6):2166-74. PubMed ID: 1281826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T cell hyper-responsiveness in CD45 transgenic mice is independent of isoform.
    Salmond RJ; McNeill L; Holmes N; Alexander DR
    Int Immunol; 2008 Jul; 20(7):819-27. PubMed ID: 18448457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms.
    Xu Z; Weiss A
    Nat Immunol; 2002 Aug; 3(8):764-71. PubMed ID: 12134145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite.
    Takakura K; Beckman JS; MacMillan-Crow LA; Crow JP
    Arch Biochem Biophys; 1999 Sep; 369(2):197-207. PubMed ID: 10486138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
    Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
    J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation-dependent interaction of Jacalin with CD45 induces T lymphocyte activation and Th1/Th2 cytokine secretion.
    Baba M; Yong Ma B; Nonaka M; Matsuishi Y; Hirano M; Nakamura N; Kawasaki N; Kawasaki N; Kawasaki T
    J Leukoc Biol; 2007 Apr; 81(4):1002-11. PubMed ID: 17242371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatases in T cell physiology.
    Mustelin T; Alonso A; Bottini N; Huynh H; Rahmouni S; Nika K; Louis-dit-Sully C; Tautz L; Togo SH; Bruckner S; Mena-Duran AV; al-Khouri AM
    Mol Immunol; 2004 Jul; 41(6-7):687-700. PubMed ID: 15220004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation.
    Laxminarayana D; Kammer GM
    J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential regulation of Lck kinase phosphorylation sites by CD45 is critical for T cell receptor signaling responses.
    McNeill L; Salmond RJ; Cooper JC; Carret CK; Cassady-Cain RL; Roche-Molina M; Tandon P; Holmes N; Alexander DR
    Immunity; 2007 Sep; 27(3):425-37. PubMed ID: 17719247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential requirements of CD45 protein tyrosine phosphatase for cytolytic activities and intrathymic and extrathymic development of intestinal intraepithelial lymphocytes.
    Yada S; Kishihara K; Kong YY; Nomoto K
    J Immunol; 1998 Sep; 161(5):2208-16. PubMed ID: 9725213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface expression of hemopoietic cell phosphatase fails to complement CD45 deficiency and inhibits TCR-mediated signal transduction in a Jurkat T cell clone.
    Musci MA; Beaves SL; Ross SE; Yi T; Koretzky GA
    J Immunol; 1997 Feb; 158(4):1565-71. PubMed ID: 9029091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.